A Clinical Trial for a Rare Pancreatic Cancer
Allison Lippman Kuban was trying to tolerate a difficult chemotherapy regimen when a mutation was found that qualified her for a clinical trial.
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
Finding Qualified Doctors Made All the Difference
Lee Ringuette’s first doctor was not experienced with pancreatic cancer, so he found other doctors willing to try new treatment protocols.
Important Questions When Starting Pancreatic Cancer Treatment
Dr. Gauri Varadhachary outlines the important questions to ask when you start treatment with surgery, chemotherapy, or radiation for pancreatic cancer.
Targeting AXL May Improve Chemotherapy for Pancreatic Cancer
Dr. Shaalan Beg describes a clinical trial using the kinase inhibitor bemcentinib along with chemotherapy as a way to slow down or stop pancreatic cancer.
Living with Pancreatic Cancer as a Long-Term Survivor
I first learned about pancreatic cancer in 1998, when my father was diagnosed with the disease. He died two months…
Life With Pancreatic Cancer and on Clinical Trials
After a pancreatic cancer diagnosis, former basketball coach and GM Rob Babcock realized his best chance was with clinical trials.
Molecular Sequencing Leads to Customized Treatment
When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.
Finding a Safe Dose of a New Drug for Some Types of Solid Tumors
LMB-100 is a lab-created protein that targets mesothelin. It is being tested against pancreatic cancer and other solid tumors in a clinical trial.
Don’t Ignore Your Symptoms
It took Ed Duncan a long time to recognize that the symptoms he had added up to a very serious disease: pancreatic cancer.
